New York, NY, March 22, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Joint Pain Injections Market By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, And Others), By Joint Type (Knee And Ankle, Hip, Shoulder And Elbow, And Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030” in its research database.
“According to the latest research study, the demand of global Joint Pain Injections Market size & share in terms of revenue was valued at USD 4.75 billion in 2021 and it is expected to surpass around USD 10.75 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 7.9% during the forecast period 2022 to 2030.”
What are Joint Pain Injections? How big is the Joint Pain Injections Industry?
Joint Pain Injections Report Coverage & Overview:
Joint pain injections are inoculated in joints for relieving pain and reducing swelling as well as discomfort in patients. An increase in number of patients suffering from joint ailments and unmet medical conditions has spurred the demand for joint pain injections. With the massive occurrence of joint pains witnessed in the elderly population and the easy availability of effective treatments have enhanced the popularity of joint pain injections in the healthcare sector. Massive focus on improving the healthcare infrastructure has culminated in humungous growth for the joint pain injections industry along with adding value proposition to the medical device.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/joint-pain-injections-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 195+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Global Joint Pain Injections Market: Growth Dynamics
Rise in cases of arthritis and musculoskeletal conditions has resulted in large-scale demand for joint pain injections for treating such medical conditions. This is predicted to be a key factor in the expansion of the global joint pain injections market. Burgeoning demand for cost-efficient medical treatment for age-related disorders such as osteoarthritis will prompt the growth of the global industry in the years ahead. Launching of new technologies in the healthcare sector and the growing requirement of reducing pain and inflammation in knee and joints will boost global business trends.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/joint-pain-injections-market
Nonetheless, the surge in costs of joint pain injections along with less awareness about the relief and comfort provided by these products to joints can impede the global market growth. However, an increase in fund allocation to research & development activities related to medical research will proliferate the size of the global market and will provide the industry with new growth opportunities.
Report Scope
| Report Attribute | Details |
| Market Size in 2021 | USD 4.75 billion |
| Projected Market Size in 2030 | USD 10.75 billion |
| CAGR Growth Rate | 7.9% CAGR |
| Base Year | 2021 |
| Forecast Years | 2022-2030 |
| Key Market Players | Seikagaku Corporation, Zimmer Biomet Holdings Inc., Dr. Reddy's Laboratories, Chugai Pharmaceutical Co., Ltd, Flexion Therapeutics, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Wright Medical Group N.V., Anika Therapeutics Inc., Bioventus, Ferring Pharmaceuticals, and Pfizer, Inc. |
| Key Segment | By Product, By Joint Type, By Distribution Channel and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Joint Pain Injections Market: Segmentation Analysis
The global joint pain injections market is sectored into product, joint type, distribution channel, and region.
On basis of product, the global joint pain injections industry is divided into corticosteroid injections, platelet-rich plasma injections, hyaluronic acid injections, and others. Furthermore, the platelet-rich plasma injections segment is expected to record the fastest CAGR over the assessment period. The growth of the segment can be attributed to increase in the clinical trials performed on patients to empirically prove the effectiveness of joint pain treatment on patients. Moreover, a rise in the rate of approval of platelet-rich plasma injection treatment for people suffering from joint pain is likely to help the global market ascend to new heights of growth.
Based on joint type, the global joint pain injections market is divided into knee and ankle, shoulder and elbow, hip, and others segments. Furthermore, the knee and ankle segment is predicted to account majorly towards the global market share over the forecast timespan. The segmental growth can be attributed to the exponential demand for intra-articular injections for efficiently managing knee pain and treating osteoarthritis of the knee.
In terms of distribution channel, the global joint pain injections industry is segmented into retail pharmacies, online pharmacies, and hospital pharmacies segments. Moreover, the hospital pharmacies segment accounted lucratively towards the global joint pain injections market share in 2021. The segmental expansion is attributed to the growing necessity of hospitalizing subjects suffering from orthopedic & autoimmune disorders such as osteoarthritis and rheumatoid arthritis. Nonetheless, the retail pharmacies segment is predicted to account remarkably for the global industry share over the forecast timespan. The segmental growth from 2022 to 2030 can be credited to the large-scale presence of a robust retail pharmacy network across the globe.
Get Infographics: https://www.zionmarketresearch.com/content/uploadedimages/global-joint-pain-injections-market.png
The global Joint Pain Injections market is segmented as follows:
The global joint pain injections market is sectored into product, joint type, distribution channel, and region.
On basis of product, the global joint pain injections industry is divided into corticosteroid injections, platelet-rich plasma injections, hyaluronic acid injections, and others. Furthermore, the platelet-rich plasma injections segment is expected to record the fastest CAGR over the assessment period. The growth of the segment can be attributed to increase in the clinical trials performed on patients to empirically prove the effectiveness of joint pain treatment on patients. Moreover, a rise in the rate of approval of platelet-rich plasma injection treatment for people suffering from joint pain is likely to help the global market ascend to new heights of growth.
Based on joint type, the global joint pain injections market is divided into knee and ankle, shoulder and elbow, hip, and others segments. Furthermore, the knee and ankle segment is predicted to account majorly towards the global market share over the forecast timespan. The segmental growth can be attributed to the exponential demand for intra-articular injections for efficiently managing knee pain and treating osteoarthritis of the knee.
In terms of distribution channel, the global joint pain injections industry is segmented into retail pharmacies, online pharmacies, and hospital pharmacies segments. Moreover, the hospital pharmacies segment accounted lucratively towards the global joint pain injections market share in 2021. The segmental expansion is attributed to the growing necessity of hospitalizing subjects suffering from orthopedic & autoimmune disorders such as osteoarthritis and rheumatoid arthritis. Nonetheless, the retail pharmacies segment is predicted to account remarkably for the global industry share over the forecast timespan. The segmental growth from 2022 to 2030 can be credited to the large-scale presence of a robust retail pharmacy network across the globe.
Browse the full “Joint Pain Injections Market By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, And Others), By Joint Type (Knee And Ankle, Hip, Shoulder And Elbow, And Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030” Report at https://www.zionmarketresearch.com/report/joint-pain-injections-market
Competitive Landscape
Some of the main competitors dominating the global Joint Pain Injections market include -
- Seikagaku Corporation
- Zimmer Biomet Holdings Inc.
- Dr. Reddy's Laboratories
- Chugai Pharmaceutical Co. Ltd
- Flexion Therapeutics
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Wright Medical Group N.V.
- Anika Therapeutics Inc.
- Bioventus
- Ferring Pharmaceuticals
- Pfizer Inc.
Key Insights from Primary Research:
- According to the analysis shared by our research forecaster, the Joint Pain Injections market is likely to expand at a CAGR of around 7.9% during the forecast period (2022-2030).
- In terms of revenue, the Joint Pain Injections market size was valued at around US$ 4.75 billion in 2021 and is projected to reach US$ 10.75 billion by 2030.
- The industry is slated to expand at a notable rate due to the rise in knee and ankle injuries as well as sports injuries along with growing incidences of musculoskeletal disorders witnessed in old people.
- Based on product, hyaluronic acid injections segment accounted for the largest market share in the year 2021
- On basis of joint type, the knee and ankle segment is predicted to dominate the global market share over 2022-2030
- In terms of distribution channels, the hospital pharmacies segment accounted for the highest industry share in 2021
- On the basis of region, the North American region was the leading revenue generator for the global market in 2021
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/joint-pain-injections-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Joint Pain Injections industry?
- What are the main driving factors propelling the Joint Pain Injections Market forward?
- What are the leading companies in the Joint Pain Injections Industry?
- What segments does the Joint Pain Injections Market cover?
- How can I receive a free copy of the Joint Pain Injections Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2022−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Product, By Joint Type, By Distribution Channel and By Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7076
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
The North American region is anticipated to dominate the global joint pain injections market by 2030. The growth of the regional market can be attributed to rise in occurrence of musculoskeletal disorders, surging aging population, and strong presence of reputed players in the sub-continent. In addition to this, easy access to enhanced healthcare facilities in the region will help joint pain injections industry flourish in North America. With large number of patients opting for joint pain injections treatment in countries such as Canada and the U.S., the joint pain injections market in North America is predicted to witness an exponential surge in the foreseeable future.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Recent Developments
In December 2022, AbbVie Pharmaceuticals, a global player in biopharmaceutical industry, launched RINVOQ, a medicine used for treating adults suffering from rheumatoid arthritis and psoriatic arthritis. Reportedly, the medicine is found effective in reducing swelling, stiffness, inflammation, and pain in joints of patients affected due to psoriatic and rheumatoid arthritis. Moreover, the move will encourage firms in the joint pain injections industry to follow the suit and develop new products, thereby steering the growth of the global market.
To know an additional revised 2022 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/joint-pain-injections-market
Joint Pain Injections Market: Opportunities
Increase in patient pool suffering from arthritis to open new facades of growth for the global market
A prominent increase in the geriatric population and surge in the patient population pool suffering from arthritis has resulted in humungous demand for effective treatment for joint pains. This, in turn, has created new growth avenues for the global joint pain injections industry. In addition to this, the launching of new medical therapies for treating joint pains and an increase in the allocation of funds for medical research by private players and government agencies will promote the expansion of the global market.
Browse Other Related Research Reports from Zion Market Research:
The global non-aerosol overcaps market size was worth around USD 340 million in 2021 and is predicted to grow to around USD 485 million by 2030 with a compound annual growth rate (CAGR) of roughly 4.50% between 2022 and 2030: https://www.zionmarketresearch.com/report/non-aerosol-overcaps-market
The global portable MRI market size was worth around USD 3640 million in 2021 and is predicted to grow to around USD 6165 million by 2030 with a compound annual growth rate (CAGR) of roughly 6.82%: https://www.zionmarketresearch.com/report/portable-mri-market
Global guitar market size was worth around USD 6875 million in 2021 and is predicted to grow to around USD 11800 million by 2030 with a compound annual growth rate (CAGR) of roughly 7.0%: https://www.zionmarketresearch.com/report/guitar-market
The global cyber-physical systems (CPS) industry size was nearly $76.98 billion in 2021 and is set to increase to about $117.57 billion by 2030 with a CAGR of nearly 8.01%: https://www.zionmarketresearch.com/report/cyber-physical-systems-market
The global assistive technologies for visually impaired industry size was nearly $3.9 billion in 2021 and is set to increase to about $13.2 billion by 2030 with a CAGR of nearly 13.8%: https://www.zionmarketresearch.com/report/assistive-technologies-for-visually-impaired-market
The global bacteriophage therapy market size was nearly $42.1 million in 2021 and is set to increase to about $60.71 million by 2030 with a CAGR of nearly 4.5%: https://www.zionmarketresearch.com/report/bacteriophage-therapy-market
The global fitness ball market size was nearly $307.1 million in 2021 and is set to increase to about $607.1 million by 2030 with a CAGR of nearly 8.1%: https://www.zionmarketresearch.com/report/fitness-ball-market
The Global Lithium Titanate Batteries Market size was worth around USD 60.07 billion in 2021 and is predicted to grow to around USD 179.22 billion by 2030 with a compound annual growth rate (CAGR) of roughly 14.64%: https://www.zionmarketresearch.com/report/lithium-titanate-batteries-market
The global automated endoscope reprocessors industry size was nearly $432.1 million in 2021 and is set to increase to about $725.3 million by 2030 with a CAGR of nearly 6.0%: https://www.zionmarketresearch.com/report/automated-endoscope-reprocessors-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Rushikesh Dorge
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 7768 006 007
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: sales@zionmarketresearch.com
